Lumentum Holdings에 대한 매도 수량은 투자자에게 Lumentum Holdings의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Lumentum Holdings (NASDAQ:LITE) 주식, 공매도 수량 보고

LUMENTUM HOLDINGS INC

Lumentum Holdings

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

ASTSpaceMobile.Screenshotvideo

Mid Cap

News

Movers

Trading Ideas

ASTS

INTA

LITE

LOAR

QFIN

RKLB

다음은 지난주 큰 폭의 상승세를 보인 7개의 중형주 주식이다. 이 주식들은 여러분의 포트폴리오에 있나요? AST 스페이스모바일(NASDAQ:ASTS)의 주가는 회사가 9월 초 위성 5개를 발사할 예정이라고 발표한 후 48.26% 급등했다. 

AST 스페이스모바일 및 로켓랩은 지난주 최고 성과를 보여준 7개 중형주 중 일부 (8월 11일-8월 17일)

What The CFO Said

Earnings

Pre-Market Outlook

Markets

BABA

TITN

목요일 오전 (현지 시간 기준) 미국 주식 선물이 더 높게 거래되면서 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다: 월스트리트는 월마트(NYSE:WMT)가 개장 전 1,685억 7천만 달러의 매출과 주당 0.64달러의 분기 이익을 보고할 것으로 예상하고 있다. Benzinga Pro의 데이터에 따르면 월마트의 주가는 시간외 거래에서 0.5% 상승한 69.02달러를 기록했다.

목요일 주목해야 할 주식: 월마트, 알리바바, 디어 그리고 3종목

King,County,,Washington,,United,States,-,30,January,2022:,Nvidia

Analyst Color

Long Ideas

Analyst Ratings

Tech

ANET

DELL

MRVL

NVDA

SMCI

엔비디아 (NASDAQ:NVDA)의 5년 평균 주가 대비 13% 낮은 가격에 거래되고 있다. 반면 다른 9개의 인공지능 관련 주식들이 5년 평균보다 높은 가격에 거래되고 있다. 모든 10개 주식의 인공지능 평균이 52% 프리미엄에 거래되고 있다고 JP모건의 사믹 채터지(Samik Chatterjee)가 분석 노트에서 블룸버그의 데이터를 인용하여 설명했다.

엔비디아는 장기 평균 대비 13% 할인되어 거래 vs 다른 AI 기업 주식은 52% 프리미엄에 거래

Lumentum Holdings Inc

Lite Access Technologies Inc

Litecoin - TrueUSD

Litecoin - United States Dollar

Litecoin Cash

Litentry - United States Dollar

Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) on Monday presented data from the phase 3 REAL8 basket study investigating once-weekly Sogroya&nbsp;(somapacitan) in four different but related growth disorder indications, including small for gestational age (SGA), Turner syndrome (TS), Noonan syndrome (NS), and idiopathic short stature (ISS) <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">under one trial protocol</a>.
In REAL8, pre-pubertal children with NS, TS, or ISS were randomized to receive either once-weekly Sogroya&nbsp;(somapacitan) 0.24 mg/kg/week or once-daily somatropin 0.050 mg/kg/day.
Children born SGA were <a target="_blank" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916003" rel="noreferrer noopener">randomized</a> to receive either somapacitan 0.24 mg/kg/week, a low dose of somatropin 0.035 mg/kg/day, or a high dose of somatropin 0.067 mg/kg/day.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/05/45341590/trumps-drug-pricing-executive-order-could-rattle-pharma-stocksprice-cuts-up-to-80" rel="noreferrer noopener">Trump&#8217;s New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&amp;J Fall In Premarket</a>
The trial showed that once-weekly Sogroya was non-inferior to the once-daily growth hormone Norditropin&nbsp;(somatropin) in improving yearly growth rate (as measured by height velocity or HV at Week 52).
In addition, once-weekly Sogroya was superior to daily growth hormone in children with NS and to lower doses of daily growth hormone in children born SGA.
REAL8 data showed that Sogroya&nbsp;was well-tolerated, with no safety or tolerability issues identified compared to once-daily growth hormone.
Results from the Turner syndrome (TS) sub-study of REAL8 will be available later this year.
The REAL8 trial achieved its primary endpoints for the first three sub-studies, demonstrating that once-weekly Sogroya&nbsp;was non-inferior to once-daily growth hormone treatment at Week 52 across the three indications presented:
<ul class="wp-block-list">
<li>In children born SGA, Sogroya&nbsp;demonstrated superior estimated mean HV when compared with a lower dose (0.035 mg/kg/day) of somatropin (11.0 vs 9.4 cm/year) and non-inferior estimated mean HV when compared with a higher dose (0.067 mg/kg/day) of somatropin (11.0 vs 11.1 cm/year).</li>
<li>Sogroya&nbsp;demonstrated superior estimated mean HV in children with NS compared with somatropin (10.4 vs 9.2 cm/year).</li>
<li>Sogroya&nbsp;demonstrated non-inferior estimated mean HV in children with ISS compared with daily somatropin (10.5 vs 10.5 cm/year).</li>
<li>In April 2025, based on the data from REAL8 and REAL9, the three indications (SGA, NS, and ISS) were submitted for regulatory review in both the EU and the U.S.</li>
</ul>
Price Action: NVO stock is down 3.00% to $63.80 during the premarket session at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45328107/shopify-shows-strong-global-momentum-but-guidance-raises-questions-on-profitability-path" target="_blank" rel="noreferrer noopener">Shopify Shows Strong Global Momentum, But Guidance Raises Questions On Profitability Path</a></li>
</ul>
Image via Shutterstock

Biotech

Large Cap

Health Care

General

Novo Nordisk's Sogroya Supports Effective Weekly Alternative To Daily Hormone Therapy Across Three Growth Disorders

Guggenheim analyst Debjit Chattopadhyay maintains Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) with a Buy and lowers the price target from $55 to $45.

Price Target

NTLA

Guggenheim Maintains Buy on Intellia Therapeutics, Lowers Price Target to $45

New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) (the "Company") is rescheduling the announcement of its financial results for the first quarter of 2025 to Wednesday, May 14th, 2025 at 4:00 P.M. Eastern Time to announce the closing of the Jamaica transaction, and announce an update to the use of proceeds. A copy of the press release and an earnings supplement will be posted to the Investors section of the Company's website, <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.newfortressenergy.com&amp;esheet=54253060&amp;newsitemid=20250512039219&amp;lan=en-US&amp;anchor=www.newfortressenergy.com&amp;index=1&amp;md5=e3938874f7198884392d06c505510a99">www.newfortressenergy.com</a>.
The Company will hold a conference call on Wednesday, May 14th, 2025 at 4:30 P.M. Eastern Time. The conference call may be accessed by dialing (888) 256-1007 (toll-free from within the U.S.) or +1 (323) 701-0225 (from outside of the U.S.) fifteen minutes prior to the scheduled start of the call; please reference "NFE First-Quarter 2025 Earnings Call" or conference code 8378656.

New Fortress Energy Reschedules Q1 2025 Earnings Release And Conference Call To May 14, 2025

D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) with a Buy and maintains $10 price target.

TVGN

D. Boral Capital Maintains Buy on Tevogen Bio Holdings, Maintains $10 Price Target

WIIM

GD Culture Group shares are trading higher after the company announced a $300 million stock purchase agreement to support its crypto treasury expansion.

Mitsubishi Estate Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MITEY#OTC">MITEY</a>) reported quarterly earnings of $0.44 per share. This is a 8.33 percent decrease over earnings of $0.48 per share from the same period last year. The company reported $3.49 billion in sales this quarter. This is a 10.47 percent decrease over sales of $3.90 billion the same period last year.

MITEY

Mitsubishi Estate Co Q4 EPS $0.44 Down From $0.48 YoY, Sales $3.49B Down From $3.90B YoY

<ul>
<li>TSLA</li>
<li>GLD</li>
<li>NVDA</li>
<li>BULL</li>
<li>GOOGL</li>
<li>GOOG</li>
<li>QQQ</li>
<li>AAPL</li>
<li>AMZN</li>
<li>MSTR</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

AMZN

BULL

GOOG

GOOGL

MSTR

TSLA

Top 10 Trending Stocks On WallStreetBets As Of May 12, 2025 (Via Swaggy Stocks)

SHOP

Reported May 9, 2025: Shopify To Join The Nasdaq-100 Index Beginning May 19, 2025

Guggenheim analyst Michael Morris maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $675 to $725.

SPOT

Guggenheim Maintains Buy on Spotify Technology, Raises Price Target to $725

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>D. Boral Capital analyst Jason Kolbert initiated coverage on NeuroSense Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRSN#NASDAQ">NRSN</a>) with a Buy rating and announced a price target of $14. NeuroSense Therapeutics shares closed at $1.0438 on Friday. <a href="https://www.benzinga.com/quote/NRSN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Jason McCarthy initiated coverage on ProMIS Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMN#NASDAQ">PMN</a>) with a Buy rating and announced a price target of $3. ProMIS Neurosciences shares closed at $0.5020 on Friday. <a href="https://www.benzinga.com/quote/PMN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group initiated coverage on Primis Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) with a Buy rating and announced a price target of $1. Primis Finl shares closed at $8.96 on Friday. <a href="https://www.benzinga.com/quote/FRST/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NRSN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="606" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-1024x606.png" alt="" class="wp-image-911914" style="width:576px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-1024x606.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-768x455.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45342900/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-5">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Initiation

FRST

NRSN

This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/05/09/final-trades-vertex-pharma-palantir-wynn-resorts-and-microsoft.html">Halftime Report Final Trades</a>,&#8221; Brenda Vingiello, Chief Investment Officer of Sand Hill Global Advisors, picked Wynn Resorts, Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) as her final trade.
Wynn Resorts, on May 6, reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.19 per share. The company reported quarterly sales of $1.7 billion which missed the analyst consensus estimate of $1.74 billion.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here </a>
Stephen Weiss, Chief Investment Officer of Short Hills Capital Partners, named Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>), <a href="https://in.benzinga.com/general/biotech/25/05/45208824/vertex-pharmaceuticals-stock-falls-on-q1-earnings-revenue-miss-company-raises-low-end-of-fy25-revenue-guidance">saying it will bounce</a>.
On the earnings front, Vertex reported first-quarter adjusted earnings per share of $4.06 on May 5, down from $4.76 a year ago and missing the consensus of $4.32. The cystic fibrosis-focused company reported sales of $2.77 billion, missing the consensus of $2.85 billion.
Kevin Simpson, Capital Wealth Planning CIO, said Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) reported impressive earnings, with revenue gaining 39% in the first quarter.
Citigroup analyst Tyler Radke raised the price target on the stock from $110 to $115 on May 8, supporting her view.
Jim Lebenthal of Cerity Partners, named Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) as his final trade.
On April 30, Microsoft reported stronger-than-expected financial results for the third quarter and also issued strong revenue guidance.
Price Action:
<ul class="wp-block-list">
<li>Vertex Pharmaceuticals shares fell 1.1% to close at $424.99 on Friday.</li>
<li>Palantir Technologies shares slipped 1.6% to settle at $117.30 during Friday's session.</li>
<li>Wynn Resorts shares rose 1.6% to close at $87.93 on Friday.</li>
<li>Microsoft shares climbed 0.1% to settle at $438.73.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a></li>
</ul>

Media

MSFT

PLTR

VRTX

WYNN

Wynn Resorts, Microsoft, Palantir And A Health Care Stock On CNBC's 'Final Trades'

Gryphon Digital Mining, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares are trading higher premarket at the last check on Monday after it disclosed a definitive stock-for-stock merger deal with American Bitcoin, a majority-owned subsidiary of Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/ac45343018/gryphon-digital-mining-announces-merger-with-american-bitcoin" rel="noreferrer noopener">for an undisclosed amount</a>.
Upon closing, the combined entity will operate under the American Bitcoin brand and is expected to trade on Nasdaq under the ticker &#8220;ABTC.&#8221;
Notably, in collaboration with Eric Trump, Hut 8 launched American Bitcoin earlier this year.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45324398/hut-8-analysts-still-bullish-despite-q1-miss-bets-on-american-bitcoin-hpc-ai-potential" rel="noreferrer noopener">Hut 8 Analysts Still Bullish Despite Q1 Miss; Bets On American Bitcoin, HPC/AI Potential</a>
This venture aims to establish the world&#8217;s largest and most efficient pure-play Bitcoin mining operation, complemented by a substantial strategic Bitcoin reserve.
American Bitcoin is specifically designed to facilitate Bitcoin accumulation at scale through cost-effective mining practices and other synergistic strategies.
The transaction is projected to close as early as the third quarter of 2025, contingent upon fulfilling certain closing conditions.
Upon the transaction&#8217;s completion, it is anticipated that existing Gryphon stockholders will hold roughly 2% of the combined company, while former American Bitcoin stockholders will own approximately 98%.
Asher Genoot, Board Member of American Bitcoin and CEO of Hut 8 said, &#8220;Time-to-market was a critical factor, and this transaction enables an efficient path to public markets by combining with an entity that is structurally aligned with American Bitcoin&#8217;s mining-focused launch strategy.&#8221;
As of March 31, cash and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/ac44571035/gryphon-digital-mining-reports-fourth-quarter-and-fy-2024-financial-results" rel="noreferrer noopener">cash equivalents stood at $735k</a>.
Price Action: GRYP shares are up 303.9% to $2.10 premarket at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/44849610/bitcoin-miners-buckle-under-april-price-pressure-but-jp-morgan-analyst-says-mara-cleanspark-held-strong" target="_blank" rel="noreferrer noopener">Bitcoin Miners Buckle Under April Price Pressure, But JP Morgan Analyst Says MARA, CleanSpark Held Strong</a></li>
</ul>
Image by Wit Olszewski via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Small Cap

GRYP

Gryphon Digital To Take Trump-Affiliated American Bitcoin Public In Merger Deal, Stock Soars

GD Culture Group Limited ("GDC" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>), and its subsidiary, AI Catalysis Corp. ("AI Catalysis"), today announced that it has entered into a Common Stock Purchase Agreement (the "Agreement") with an accredited investor (an "Investor"), a British Virgin Island limited liability company, providing for the sale by the Company of up to $300 million of its common stock.
Proceeds from the facility will be used to support the Company's crypto asset treasury strategy, including the purchase of Bitcoin ("BTC") and OFFICIAL TRUMP ("TRUMP"). Under this initiative, and subject to certain limitations, GDC intends to allocate a significant portion of the proceeds from any share sales under the facility to the acquisition, long-term holding, and integration of crypto assets into its core treasury operations. This strategic move reflects the Company's commitment to and confidence in the ongoing decentralization transformation.

GD Culture Group Announces $300M Common Stock Purchase Agreement with Accredited Investor; Proceeds To Be Used To Support Company's Crypto Treasury Expansion

The United States and China agreed to slash their retaliatory tariffs by over 100 percentage points, pausing a spiraling trade war that had threatened<a href="https://www.benzinga.com/news/econ-s"> to choke global growth.</a>
<h3 class="wp-block-heading">What's In The Deal?</h3>
The agreement establishes a 90-day reset, slashing U.S. tariffs on Chinese goods from 145% to 30%, and Chinese tariffs on U.S. goods from 125% to 10%, starting May 14. 
The decision stems from high-level negotiations in Geneva, led by U.S. Treasury Secretary Scott Bessent and China's Vice Premier He Lifeng.
The truce halts one of the steepest protectionist escalations in recent history, following President Donald Trump's aggressive "Liberation Day" trade tariffs launched on April 2.
"We reached an agreement on a 90-day pause and substantially moved down the tariff levels," Bessent said in a press conference. 
"Both countries represented their national interests very well, but we concluded we have shared interest in balanced trade."
<h3 class="wp-block-heading">Tariff Truce Cools Recession And Inflation Risks</h3>
The tariff rollback offers more than diplomatic relief — it also addresses growing fears of a U.S. economic slowdown and resurgent inflation. By averting the triple-digit import taxes that threatened to choke global trade, the deal removes a significant source of economic uncertainty that had weighed on business investment and consumer confidence.
Recession probabilities have sharply declined in response. 
The latest market-based forecast from Kalshi shows a 46% chance of a U.S. recession this year, down from 60% at the end of April, reflecting improving sentiment. Notably, consumer spending and corporate earnings had begun showing early signs of strain under the tariff shock imposed in April.
On the inflation front, the agreement is expected to ease price pressures on goods most impacted by the trade war — including electronics, automotive parts and industrial equipment.
Ahead of Tuesday's official April Consumer Price Index report, economists expect a return to monthly inflation growth: headline prices are forecast to rise 0.3%, reversing March's 0.1% dip. Core inflation is also expected to rise 0.3%, while annual inflation rates are seen holding steady at 2.4% for headline and 2.8% for core.
<h3 class="wp-block-heading">Why Markets Cheered</h3>
U.S. equity futures soared as the news hit, with futures on the S&amp;P 500 climbing 3.13% to 5,836.66, those on the Nasdaq 100 jumping 4.05%, and Dow futures up 2.62%. 
The U.S. dollar index – as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – surged 1.4%, with the greenback rallying 2% against the Japanese yen. 
Meanwhile, 2-year Treasury yields rose 10 basis points to 4%, as traders dialed back expectations for a near-term Federal Reserve rate cut. The odds of a June cut fell to 11%, down from 25% a week ago, per CME FedWatch.
Gold – as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) – dropped 2.9%, with investors rotating out of safe havens, and oil climbed 3.9% to $63.40 amid improving global demand prospects.
<h3 class="wp-block-heading">Who Wins On Wall Street?</h3>
U.S. equities rallied sharply as investors welcomed the truce between Washington and Beijing. 
Trade-sensitive and consumer-facing stocks led the premarket advance, reflecting relief over lower input costs and reduced supply chain disruption. Technology and industrials also posted notable gains.
Top Gainers – S&amp;P 500
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stanley Black &amp; Decker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>)</td>
<td>+12.07%</td>
</tr>
<tr>
<td>Best Buy Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>)</td>
<td>+10.42%</td>
</tr>
<tr>
<td>Microchip Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>)</td>
<td>+9.29%</td>
</tr>
<tr>
<td>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>)</td>
<td>+8.94%</td>
</tr>
<tr>
<td>NRG Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>)</td>
<td>+8.08%</td>
</tr>
</tbody>
</table>
</figure>
Top Premarket Gainers – Nasdaq 100
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Microchip Technology Inc.</td>
<td>+9.29%</td>
</tr>
<tr>
<td>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>)</td>
<td>+8.94%</td>
</tr>
<tr>
<td>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>+8.44%</td>
</tr>
<tr>
<td>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</td>
<td>+8.07%</td>
</tr>
<tr>
<td>ON Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>)</td>
<td>+8.02%</td>
</tr>
</tbody>
</table>
</figure>
Top Premarket Losers – S&amp;P 500
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Newmont Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>)</td>
<td>-5.24%</td>
</tr>
<tr>
<td>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>)</td>
<td>-3.60%</td>
</tr>
<tr>
<td>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)</td>
<td>-3.58%</td>
</tr>
<tr>
<td>Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)</td>
<td>-3.38%</td>
</tr>
<tr>
<td>Westinghouse Air Brake Technologies Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>)</td>
<td>-3.17%</td>
</tr>
</tbody>
</table>
</figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling">Apple, Amazon, Nvidia Rise In Monday Premarket As US, China Agree To 90-Day Tariff Truce: &#8216;Neither Side Wants A Decoupling&#8217;</a><span class="author" style="box-sizing: border-box; border: 0px solid rgb(229, 231, 235); --tw-scale-x: 1; --tw-scale-y: 1; --tw-pan-x: ; --tw-pan-y: ; --tw-pinch-zoom: ; --tw-scroll-snap-strictness: proximity; --tw-gradient-from-position: ; --tw-gradient-via-position: ; --tw-gradient-to-position: ; --tw-ordinal: ; --tw-slashed-zero: ; --tw-numeric-figure: ; --tw-numeric-spacing: ; --tw-numeric-fraction: ; --tw-ring-inset: ; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgba(59,130,246,.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; --tw-blur: ; --tw-brightness: ; --tw-contrast: ; --tw-grayscale: ; --tw-hue-rotate: ; --tw-invert: ; --tw-saturate: ; --tw-sepia: ; --tw-drop-shadow: ; --tw-backdrop-blur: ; --tw-backdrop-brightness: ; --tw-backdrop-contrast: ; --tw-backdrop-grayscale: ; --tw-backdrop-hue-rotate: ; --tw-backdrop-invert: ; --tw-backdrop-opacity: ; --tw-backdrop-saturate: ; --tw-backdrop-sepia: ; --tw-contain-size: ; --tw-contain-layout: ; --tw-contain-paint: ; --tw-contain-style: ;"></li>
</ul>
Photo: emin kuliyev/Shutterstock

Government

Regulations

Bonds

Forex

Econ #s

ETFs

ABBV

GEHC

GILD

MCHP

PowerShares DB US Dollar Index Bullish Fund

Wall Street Rips Higher As Tariff Truce Halts US–China Economic Escalation

Gryphon Digital Mining shares are trading higher after the company announced a merger agreement with American Bitcoin.

FEATURING ALL OF FOX'S PREMIUM NEWS, SPORTS AND ENTERTAINMENT PROGRAMMING IN ONE DYNAMIC PLATFORM
NEW YORK and LOS ANGELES, May 12, 2025 /PRNewswire/ -- Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>, FOX)))&nbsp;today introduced FOX One, its wholly-owned direct to consumer streaming service. FOX One will bring all of FOX's leading News, Sports and Entertainment branded content together in one dynamic streaming platform.&nbsp;
For the first time, cord-cutters and cord-nevers will have live streaming and on-demand access to the full portfolio of FOX brands including FOX News, FOX Business, FOX Weather, FOX Sports, FS1, FS2, BTN, FOX Deportes, FOX Local Stations and the FOX network as well as the option to bundle FOX Nation within one platform.

FOXA

FOX Launches 'FOX One' Direct-To-Consumer Streaming Service Combining Live And On-Demand Access To Entire Portfolio Including FOX News, FOX Sports, FOX Entertainment, Local Stations, FS1, FS2, FOX Weather, And More

SDRL

Seadrill shares are trading lower following a Q1 EPS miss.

Goldman Sachs analyst Olivier Nicolai upgrades Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) from Neutral to Buy and raises the price target from $70.1 to $88.

Upgrades

Goldman Sachs Upgrades Anheuser-Busch InBev to Buy, Raises Price Target to $88

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4424402-1&amp;h=1455207525&amp;u=http%3A%2F%2Fwww.zynex.com%2F&amp;a=Zynex%2C+Inc">Zynex, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>),&nbsp;an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for its NiCO&#x2122;, Noninvasive CO-Oximeter device.
This submission marks a historic milestone in the evolution of pulse oximetry and a major breakthrough for the Company in its mission to improve the quality of care and patient outcomes through its patient monitoring products. Pulse oximetry is one of the world's largest medical device markets and current devices on the market have long been under scrutiny for their inaccuracy and limitations. Zynex's laser technology enables oxygen levels to be measured accurately for patients with dark skin. In cases of carbon monoxide (CO) poisoning, not only are the measurements non-invasive and results instantaneous, but both oxygen and CO are measured accurately, potentially reducing the need for taking blood samples and having to wait for the lab results.
 &nbsp;

ZYXI

Zynex Submits 510(k) Application To FDA For NiCO, Noninvasive Co-Oximeter Device

LINC

Lincoln Educational Services shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates.

Press Releases

Lumentum Optical Circuit Switch to Improve Next-Generation AI Data Center Scalability

Lumentum to Showcase Cutting-Edge Optical Innovations for Cloud, AI, and Networking Infrastructure at OFC 2025

Lumentum and Marvell Showcase Industry's First Integrated 450G High-Speed Optical Interface at OFC 2025

Lumentum Unveils New Transceivers to Double Fiber Capacity Across Wide Range of Transmission Distances

Lumentum Showcases Next-Generation InP Chip Solutions Enabling Scalable AI Data Centers at OFC 2025

Lumentum Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market

Lumentum Earns EcoVadis Platinum Medal for Third Consecutive Year

Lumentum to Announce Fiscal Third Quarter 2025 Financial Results on May 6, 2025

Lumentum Announces Upcoming Investor Events

Lumentum Announces Fiscal Third Quarter 2025 Financial Results

Applied Optoelectronics, Inc. - Common Stock

Applied Optoelectronics

Adtran Holdings

Arista Networks

Aviat Networks

Calix

Ciena

Clearfield

CommScope Holding Company, Inc. - Common Stock

CommScope Holding Co

Cisco Systems

Digi Intl

Ericsson - American Depositary Shares each representing 1 underlying Class B share

Comments

Lumentum Holdings

매도 수량

Lumentum Holdings (NASDAQ:LITE) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌